Bayer AG Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/10/2026)
| Balance Sheet | Total Assets | 110,606,000,000.00 | ROE | 23.46 % |
| Balance Sheet | Total Equity | 25,947,000,000.00 | ROA | -3.27 % |
| Cashflow | Capital Expenditures | -2,487,000,000.00 | P/FCF | 21.25 |
| Cashflow | Free Cash Flow | 2,084,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 4,571,000,000.00 | P/CF | 9.69 |
| Income | Earnings per Share (diluted) | -3.68 | Div. Yield | 0.24 % |
| Income | Net Income | -3,620,000,000.00 | P/E | -12.25 |
| Income | Shares Outstanding | 982,420,000.00 | P/B | 1.71 |
| Income | Total Revenue | 45,575,000,000.00 | P/S | 0.97 |
Ratios calculated on: 10/14/2026
Company Description
Bayer AG is a German management holding company with core competencies in the field of health care, nutrition and high-tech materials. It's business operations are organized into three subgroups: HealthCare, involved in the research, development and manufacture of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control, and MaterialScience, that provides polymers, and develops solution for a range of applications, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. It operates through numerous subsidiaries, affiliated companies as well as joint ventures located in Europe, Latin America, Africa, Middle East, North America as well as the Asia/Pacific region, such as Bayer Chemicals AG in Germany, Cotton Growers Services Pty. Limited in Australia and Bayer Israel Ltd in Israel, among others
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.bayer.de
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more